Source: GWASDB
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
heme oxygenase 1 | 0.381 | 0.923 | 9.7E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2012 | 2012 | ||||||||
|
hematopoietic prostaglandin D synthase | 0.388 | 0.923 | 1.8E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2010 | 2019 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
nuclear receptor subfamily 1 group I member 2 | 0.418 | 0.846 | 7.3E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
interleukin 15 | 0.422 | 0.846 | 0.71 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2018 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
cytochrome P450 family 2 subfamily B member 6 | 0.428 | 0.846 | 1.9E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2012 | 2017 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
notch receptor 3 | 0.435 | 0.808 | 0.41 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
MEFV innate immuity regulator, pyrin | 0.440 | 0.885 | 1.0E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2018 |